Breaking Through
TB Alliance Annual Report 2019
CEO LETTER
A Message from the CEO and Board Chair
We expect to look back on 2019 as a decisive year for TB Alliance.
ACCESS
More Than One Million Child-Friendly Treatment Courses Ordered
The new medicines are easier for caregivers to give and for children to take, and the formulations have now been ordered by more than 90 countries.
R&D
New Therapy Shows Promise of Regimen Development
Treating TB requires a combination of drugs, and advances in therapy had hinged on the development of individual drugs. We developed a new approach.
Partnerships
Partnerships in Practice
None of our work would be possible without the continued commitment of our diverse network of partners.
TB Alliance in 2019
An overview of the milestones TB Alliance achieved toward our goal to develop new, better treatments for all forms of TB.